Subscribe to My Feed




Tell a Friend




  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • A Call for Scaled-Up R&D for Neglected Diseases / Una llamada para más I+D para las enfermedades olvidadas / Uma chamada para aumento de P&D sobre as doenças negligenciadas

    Monday, February 23rd, 2009

    From the Drugs for Neglected Diseases initiative (DNDi): MSF and DNDi Call for Scale-Up of R&D for Neglected Diseases Greater Governmental Leadership is needed to Foster Medical Innovation for Millions Suffering from Neglected Diseases The international medical humanitarian organization Médecins Sans Frontières (MSF) and the Drugs for Neglected Diseases initiative (DNDi) called today for more […]

    Share

    An Affordable Anti-Malarial / Um medicamento para malária a preço mais acessível

    Wednesday, August 20th, 2008

    From Drugs for Neglected Diseases initiative (DNDi): Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) welcome the agreement announced by Clinton Foundation HIV/AIDS Initiative (CHAI) to reduce the volatility and the price […]

    Share

    A Safe, Easy to Use Chagas Treatment for Children / Un tratamiento más seguro y fácil para los niños infectados con la enfermedad de Chagas

    Monday, August 18th, 2008

    From the Drugs for Neglected Diseases Initiative (DNDi): Chagas Disease Partnership Will Deliver Safe, Easy-to-Use Treatment for Children An agreement between Drugs for Neglected Diseases initiative (DNDi) and the Pharmaceutical Laboratory of Pernambuco (Lafepe) will deliver the first pediatric formulation of benznidazole, the most widely used drug for the treatment of Chagas disease, at cost […]

    Share